Charlie Petty brings a VC's mindset to problems in global health by making venture investments into companies launching products with outsized benefits to public health.

Brian Finrow wants to make antibodies and other protein drugs a hundredfold or a thousandfold cheaper than other companies do today—ushering in a world of cheaper, safer, and more effective drugs.

Meri Beckwith wants "to give biotechs the ability to think and act more like tech companies" as his company, Lindus Health, disrupts the $100 billion/yr clinical trials industry.